A Human Model for Telomerase Dysfunction and Aging
A Human Model for Telomerase Dysfunction and Aging
批准号:
8049045
负责人:
ALOYSIUS John KLINGELHUTZ
金额:
$25.74万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-04-01 至 2013-03-31
关键词:
AffectAgeAgingAlopeciaBiological AssayBiological ModelsBiologyBiology of AgingCell physiologyCellsChronicDNA DamageDataDefectDevelopmentDiseaseDown-RegulationDyskeratosis CongenitaElderlyEnzymesEpidermisFibroblastsFunctional disorderGenesGoalsHumanHypopigmentationIn VitroInheritedLengthLeukoplakiaLinkMethodsModelingMutationNormal CellNormal tissue morphologyOrganOxidative StressPancytopeniaPathway interactionsPatientsPhenotypePlayPremature aging syndromeProcessProliferatingPulmonary FibrosisRNARNA-Directed DNA PolymeraseRelative (related person)Research PersonnelRoleSkinSkin AgingSomatic CellStressTelomeraseTelomerase RNA ComponentTelomere MaintenanceTelomere ShorteningTestingTissuesToxic effectWound Healingage effectagedbasebiological adaptation to stresscancer cellcancer therapycell typefollow-upinsightkeratinocytemutantnormal agingnovelnovel strategiesprogramsreconstitutionresearch studyresponserestorationsmall hairpin RNAtelomerevector
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Telomere shortening, a natural consequence of aging, and telomerase dysfunction have recently been linked with certain diseases associated with defects in highly proliferative tissue, including the epidermis. Our long-term goal is to understand the contribution of telomerase and telomere length in regulating the function and aging of human skin. Dyskeratosis congenita (DC) is an inherited "premature aging" syndrome characterized by epidermal abnormalities (e.g. leukoplakia, skin hypopigmentation, alopecia) and organ dysfunction (e.g. bone marrow failure, pulmonary fibrosis). DC is caused by mutations in genes that affect telomerase activity, resulting in shortening of telomeres in somatic cells. We recently identified an autosomal dominant form of this disease (AD DC) that is due to a deletion in hTERC, the RNA component of telomerase. AD DC provides a unique human model system to study the regulatory role of telomerase and telomere shortening in the biology of aging. We propose that telomerase and telomere length are important regulators of normal keratinocyte function, differentiation, and response to stress. Furthermore, we hypothesize that skin aging is associated with telomere length shortening and dysregulation of telomerase component expression. Using skin keratinocytes and fibroblasts isolated from AD DC subjects, normal controls and experimentally manipulated cells, we will further define the role of telomerase and telomere length in regulating DNA damage and oxidative stress response pathways. We will determine whether introduction of telomerase components, hTERC and/or hTERT, into AD DC cells restores replicative potential, cellular function, and normal responses to stress and DNA damage. We will also explore the possibility that hTERT has functions in keratinocytes that go beyond telomere maintenance and perform studies to determine whether the unusually long telomeres associated co-expression of hTERC and hTERT have any effects on cell phenotype. Overall, the experiments proposed in this application will further our understanding of the role of telomerase and telomeres in cellular defects associated with aging, and provide critical mechanistic insights into the processes that govern normal skin function and aging. Importantly, these findings may also promote the development of novel strategies aimed at reducing the effects of aging on human skin and other tissues, and in ameliorating the toxicity of cancer therapies in the elderly.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.virol.2011.12.018
发表时间:
2012-03-15
期刊:
Virology
影响因子:
3.7
作者:
[Klingelhutz AJ, Roman A]
通讯作者:
Roman A
DOI:
10.1016/j.mrfmmm.2011.05.008
发表时间:
2012-02-01
期刊:
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
影响因子:
2.3
作者:
[Gourronc, Francoise A., Klingelhutz, Aloysius J.]
通讯作者:
Klingelhutz, Aloysius J.
Dyskeratosis Congenita Dermal Fibroblasts are Defective in Supporting the Clonogenic Growth of Epidermal Keratinocytes.
先天性角化不良真皮成纤维细胞在支持表皮角质形成细胞的克隆生长方面存在缺陷。
DOI:
--
发表时间:
2012
期刊:
Aging and disease
影响因子:
7.4
作者:
[Buckingham,ErinM, Goldman,FrederickD, Klingelhutz,AloysiusJ]
通讯作者:
Klingelhutz,AloysiusJ
The role of ISG15 and ISGylation in the senescence-associated secretory phenotype
-
批准号:10788670
-
项目类别:
-
资助金额:$42.76万
-
财政年份:2023
-
负责人:ALOYSIUS John KLINGELHUTZ
-
依托单位:
A Human Model for Telomerase Dysfunction and Aging
-
批准号:7795131
-
项目类别:
-
资助金额:$26.79万
-
财政年份:2007
-
负责人:ALOYSIUS John KLINGELHUTZ
-
依托单位:
A Human Model for Telomerase Dysfunction and Aging
-
批准号:7586094
-
项目类别:
-
资助金额:$27.06万
-
财政年份:2007
-
负责人:ALOYSIUS John KLINGELHUTZ
-
依托单位:
A Human Model for Telomerase Dysfunction and Aging
-
批准号:7391533
-
项目类别:
-
资助金额:$27.06万
-
财政年份:2007
-
负责人:ALOYSIUS John KLINGELHUTZ
-
依托单位:
A Human Model for Telomerase Dysfunction and Aging
-
批准号:7263255
-
项目类别:
-
资助金额:$27.5万
-
财政年份:2007
-
负责人:ALOYSIUS John KLINGELHUTZ
-
依托单位:
The Role of Airborne PCBs in Adipogenesis, Adipose Function, and Metabolic Syndrome
-
批准号:10559684
-
项目类别:
-
资助金额:$26.03万
-
财政年份:2006
-
负责人:ALOYSIUS John KLINGELHUTZ
-
依托单位:
OVERCOMING CELLULAR SENESCENCE IN HUMAN EPITHELIAL CELLS
-
批准号:6372506
-
项目类别:
-
资助金额:$25.01万
-
财政年份:2000
-
负责人:ALOYSIUS John KLINGELHUTZ
-
依托单位:
OVERCOMING CELLULAR SENESCENCE IN HUMAN EPITHELIAL CELLS
-
批准号:6761740
-
项目类别:
-
资助金额:$22.05万
-
财政年份:2000
-
负责人:ALOYSIUS John KLINGELHUTZ
-
依托单位:
OVERCOMING CELLULAR SENESCENCE IN HUMAN EPITHELIAL CELLS
-
批准号:6532540
-
项目类别:
-
资助金额:$22.05万
-
财政年份:2000
-
负责人:ALOYSIUS John KLINGELHUTZ
-
依托单位:
OVERCOMING CELLULAR SENESCENCE IN HUMAN EPITHELIAL CELLS
-
批准号:6642035
-
项目类别:
-
资助金额:$22.05万
-
财政年份:2000
-
负责人:ALOYSIUS John KLINGELHUTZ
-
依托单位:
OVERCOMING CELLULAR SENESCENCE IN HUMAN EPITHELIAL CELLS
-
批准号:6159357
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2000
-
负责人:ALOYSIUS John KLINGELHUTZ
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: